[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10023]], camposKey:0278-5846 2024-01-01 Functional network properties in schizophrenia and bipolar disorder assessed with high-density electroencephalography107115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80595]], camposKey:0953-816X 2023-10-01 Corollary discharge function in healthy controls: Evidence about self-speech and external speech processing37053713, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50431]], camposKey:0586-7614 2023-01-01 Corollary discharge dysfunction as a possible substrate of anomalous self-experiences in schizophrenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75098]], camposKey:0940-1334 2022-11-22 Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76228]], camposKey:0940-1334 2022-10-01 A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A)12291239, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72286]], camposKey:0924-977X 2022-07-01 New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study3847, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75177]], camposKey:0278-5846 2022-06-08 Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72705]], camposKey:1741-2560 2022-02-01 Schizophrenia induces abnormal frequency-dependent patterns of dynamic brain network reconfiguration during an auditory oddball task00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68445]], camposKey:0925-4927 2022-01-01 Default mode network components and its relationship with anomalous self-experiences in schizophrenia: A rs-fMRI exploratory study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60067]], camposKey:0278-5846 2021-12-20 Event-related potentials associated to N-back test performance in schizophrenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71676]], camposKey:2162-3279 2021-12-01 Search for schizophrenia and bipolar biotypes using functional network properties00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60068]], camposKey:0940-1334 2021-06-01 Anomalous self-experiences are related to general cognition deficits in schizophrenia707712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60069]], camposKey:0920-9964 2021-03-01 Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis102111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64655]], camposKey:0213-6163 2021-01-01 Altered gamma band noise power in schizophrenia and bipolar patients during a cognitive task129139, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64563]], camposKey:0213-6163 2021-01-01 Analysis of the functional EEG network in an Ecuadorian schizophrenia sample216224, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61165]], camposKey:0213-6163 2021-01-01 Analysis of the functional EEG network in an Ecuatorian schizophrenia sample216224, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61164]], camposKey:1664-0640 2021-01-01 Editorial: New Developments With Magnetoelectrical Techniques in Schizophrenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60070]], camposKey:0920-9964 2020-08-01 Abnormal self-experiences related to a hypersynchronic brain state in schizophrenia538540, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58730]], camposKey:0213-6163 2020-01-01 Altered gamma band noise power in schizophrenia and bipolar patients during a cognitive task00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52259]], camposKey:0940-1334 2020-01-01 Analysis of KCNH2 and CACNA1C schizophrenia risk genes on EEG functional network modulation during an auditory odd-ball task433442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53628]], camposKey:0278-5846 2020-01-01 Connectivity strength of the EEG functional network in schizophrenia and bipolar disorder00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55907]], camposKey:1180-4882 2020-01-01 Deficits of Entropy Modulation of the EEG: A Biomarker for Altered Function in Schizophrenia and Bipolar Disorder?322333, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52511]], camposKey:0278-5846 2020-01-01 Identificacion of MRI-based psychosis subtypes: Replication and refinement00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60071]], camposKey:1888-9891 2019-07-01 Pattern of use of clozapine in Spain. Variability and under-prescription Patrón de uso de clozapina en España. Variabilidad e infraprescripción151162, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55313]], camposKey:1888-9891 2019-01-01 Patrón de uso de clozapina en España. Variabilidad e infraprescripción151162, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46894]], camposKey:0278-5846 2019-01-01 Social cognition in psychosis: Predictors and effects of META-cognitive training00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46888]], camposKey:0278-5846 2019-01-01 Structural connectivity in schizophrenia and bipolar disorder: Effects of chronicity and antipsychotic treatment369377, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29962]], camposKey:0940-1334 2019-01-01 Topography of activation deficits in schizophrenia during P300 task related to cognition and structural connectivity419428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49973]], camposKey:0730-725X 2018-12-01 Scalar diffusion-MRI measures invariant to acquisition parameters: A first step towards imaging biomarkers194213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37798]], camposKey:0920-9964 2018-01-01 Altered predictive capability of the brain network EEG model in schizophrenia during cognition120129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3458]], camposKey:0920-9964 2018-01-01 Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study334342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11701]], camposKey:2213-1582 2018-01-01 Deficits of entropy modulation in schizophrenia are predicted by functional connectivity strength in the theta band and structural clustering382389, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10982]], camposKey:0920-9964 2018-01-01 Early neglect associated to prefrontal structural disconnectivity in schizophrenia487488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37797]], camposKey:0925-4927 2018-01-01 Parkinsonism is associated to fronto-caudate disconnectivity and cognition in schizophrenia16, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3457]], camposKey:0129-0657 2018-01-01 Quantification of Graph Complexity Based on the Edge Weight Distribution Balance: Application to Brain Networks17500320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39296]], camposKey:1065-9471 2018-01-01 Relations between structural and EEG-based graph metrics in healthy controls and schizophrenia patients31523165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11702]], camposKey:0925-4927 2017-12-30 Biological and cognitive correlates of cortical curvature in schizophrenia6875, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3453]], camposKey:1741-2560 2017-01-01 Exploring non-stationarity patterns in schizophrenia: Neural reorganization abnormalities in the alpha band0460010, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3451]], camposKey:0278-5846 2017-01-01 Functional EEG network analysis in schizophrenia: Evidence of larger segregation and deficit of modulation116123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29960]], camposKey:1888-9891 2017-01-01 Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control3844, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55312]], camposKey:1888-9891 2017-01-01 Síndrome metabólico y antipsicóticos atípicos. Posibilidad de predicción y control: Possibility of prediction and control3844, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3454]], camposKey:0940-1334 2017-01-01 Variation at NRG1 genotype related to modulation of small-world properties of the functional cortical network2532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10007]], camposKey:0940-1334 2016-12-01 Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients743753, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60072]], camposKey:1134-5934 2016-09-01 Determinants of metabolic risk in treatment with atypical antipsychotics Factores determinantes del riesgo metabólico en el tratamiento con antipsicóticos atípicos128130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=341]], camposKey:1871-6784 2016-05-25 Neural dynamic characterization using small-world measurements in schizophrenia419419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9995]], camposKey:1557-170X 2016-01-01 Analysis of the Non-stationarity of Neural Activity during an Auditory Oddball Task in Schizophrenia37243727, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3462]], camposKey:1323-1316 2016-01-01 Association between electroencephalographic modulation, psychotic-like experiences and cognitive performance in the general population286294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15784]], camposKey:1134-5934 2016-01-01 Factores determinantes del riesgo metabólico en el tratamiento con antipsicóticos atípicos128130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10002]], camposKey:0278-5846 2016-01-01 Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics7986, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9991]], camposKey:0213-4853 2016-01-01 Impulsivity among migraine patients: Study in a series of 155 cases599605, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=434]], camposKey:0278-5846 2016-01-01 Modulation of brain network parameters associated with subclinical psychotic symptoms5462, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=379]], camposKey:0940-1334 2016-01-01 Noise power associated with decreased task-induced variability of brain electrical activity in schizophrenia5561, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10014]], camposKey:1557-170X 2016-01-01 Novel Measure of the Weigh Distribution Balance on the Brain Network: Graph Complexity Applied to Schizophrenia700703, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11703]], camposKey:1129-2369 2016-01-01 Personality traits in patients with cluster headache: a comparison with migraine patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10013]], camposKey:1888-9891 2016-01-01 Relationship between subclinical psychotic symptoms and cognitive performance in the general population7886, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10983]], camposKey:1888-9891 2016-01-01 Tineptine: Why has not been classified as a narcotic in Spain? Tianeptina: ¿por qué en España no ha sido catalogada como estupefaciente?176177, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9985]], camposKey:0210-0010 2015-07-16 Personality traits in patients with chronic migraine: a categorial and dimensional study in a series of 30 patients4956, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=450]], camposKey:1741-2560 2015-01-01 A comparative study of event-related coupling patterns during an auditory oddball task in schizophrenia0160070, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=435]], camposKey:0920-9964 2015-01-01 Auditory P3a and P3b neural generators in schizophrenia: An adaptive sLORETA P300 localization approach318325, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=471]], camposKey:0940-1334 2015-01-01 Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task525535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=443]], camposKey:1099-4300 2015-01-01 Neural Network Reorganization Analysis During an Auditory Oddball Task in Schizophrenia Using Wavelet Entropy52415256, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60073]], camposKey:0210-0010 2015-01-01 Personality traits in patients with chronic migraine: A categorial and dimensional study in a series of 30 patients Rasgos de personalidad en migraña crónica: Studio categorial y dimensional en una serie de 30 pacientes4956, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9997]], camposKey:0920-9964 2014-09-01 Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia223229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9979]], camposKey:1323-1316 2014-02-01 Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia127132, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9994]], camposKey:1744-859X 2014-01-01 Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=476]], camposKey:0940-1334 2014-01-01 Decreased spectral entropy modulation in patients with schizophrenia during a P300 task533543, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10016]], camposKey:0925-4927 2014-01-01 Frontal gamma noise power and cognitive domains in schizophrenia104113, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10022]], camposKey:0302-282X 2014-01-01 Gamma Power and Cognition in Patients with Schizophrenia and Their First-Degree Relatives120128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11160]], camposKey:1680-0737 2014-01-01 Graph-theoretical analysis in Schizophrenia performing an Auditory Oddball task799802, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42470]], camposKey:0920-9964 2014-01-01 REDUCED THETA BAND RESPONSE TO RELEVANCE IN SCHIZOPHRENIA255256, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42469]], camposKey:0920-9964 2014-01-01 SPECTRAL ENTROPY MODULATION DECREASE IN PATIENTS WITH SCHIZOPHRENIA DURING P300 EVOCATION311311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9996]], camposKey:1323-1316 2014-01-01 Structural correlates of cognitive deficit and elevated gamma noise power in schizophrenia206215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9981]], camposKey:0022-3018 2013-09-01 A Proposal for Reframing Schizophrenia Research744752, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9983]], camposKey:0920-9964 2013-09-01 Randomized trial of clozapine vs. risperidone in treatment-naive first-episode schizophrenia: Results after one year156161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10043]], camposKey:0166-4328 2013-04-01 Chronic administration of risperidone in a rat model of schizophrenia: A behavioural, morphological and molecular study178190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9990]], camposKey:0022-3956 2013-01-01 Limbic hyperactivity associated to verbal memory deficit in schizophrenia843850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11704]], camposKey:0210-0010 2013-01-01 Personality traits in patients with migraine: A multi-centre study using the salamanca screening questionnaire Rasgos de personalidad en pacientes migrañosos: Studio multicéntrico utilizando el cuestionario de cribado salamanca529534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10026]], camposKey:0033-2917 2013-01-01 Spatial distribution and cognitive correlates of gamma noise power in schizophrenia11751185, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9980]], camposKey:1139-9287 2012-09-01 Clozapine as treatment of first choice in first psychotic episodes. What do we know?281289, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40714]], camposKey:0920-9964 2012-01-01 COGNITIVE AND ELECTROPHYSIOLOGICAL CORRELATES OF NOISE POWER IN SCHIZOPHRENIA307307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10012]], camposKey:0278-5846 2012-01-01 Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia270275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50438]], camposKey:0920-9964 2012-01-01 NOISE POWER AS A MEASURE OF EVENT RELATED AND SPONTANEOUS BRAIN ACTIVITY. A LONGITUDINAL STUDY307308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10004]], camposKey:0940-1334 2011-09-01 Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics407416, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10009]], camposKey:0940-1334 2011-08-01 Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry313322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10033]], camposKey:0924-9338 2011-07-01 Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapine271275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10040]], camposKey:1053-8119 2011-05-01 Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients4551, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=334]], camposKey:0586-7614 2011-03-01 NOISE POWER DURING AUDITORY PROCESSING AND NEUROCOGNITIVE OUTCOME IN SCHIZOPHRENIC PATIENTS AND FIRST DEGREE RELATIVES. A PROSPECTIVE STUDY OF CORTICAL NOISE AS A POSSIBLE ENDOPHENOTYPIC MARKER242242, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10017]], camposKey:0940-1334 2010-12-01 No association between prepulse inhibition of the startle reflex and neuropsychological deficit in chronic schizophrenia609615, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10005]], camposKey:0925-4927 2010-10-30 Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry1622, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37799]], camposKey:0120-548X 2010-09-01 Automatic classification of structural MRI for diagnosis of neurodegenerative diseases Clasificación automática de IRM estructural para el diagnóstico de enfermedades neurodegenerativas165180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10015]], camposKey:0925-4927 2010-03-30 Voxel-based morphometry comparison between first episodes of psychosis with and without evolution to schizophrenia204210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10038]], camposKey:0166-4328 2009-12-28 Chronic administration of risperidone to healthy rats: A behavioural and morphological study488498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10020]], camposKey:0925-4927 2009-08-30 Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia8893, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10027]], camposKey:0278-5846 2009-02-01 Correlation between prepulse inhibition and cortical perfusion during an attentional test in schizophrenia5361, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10018]], camposKey:0940-1334 2008-10-01 Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder394401, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10036]], camposKey:1601-1848 2008-10-01 Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13)796801, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10006]], camposKey:0278-5846 2008-05-15 Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients948954, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10008]], camposKey:0268-1315 2008-05-01 A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia138149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10044]], camposKey:0278-5846 2008-01-01 Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics257266, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10021]], camposKey:1552-4841 2007-12-05 Effect of interleukin-1 beta gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients10901093, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10011]], camposKey:0924-9338 2007-11-01 Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder505512, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10024]], camposKey:0176-3679 2007-07-01 Changes in cortical volume with olanzapine in chronic schizophrenia135139, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10010]], camposKey:0176-3679 2007-07-01 Marked hypofrontality in clozapine-responsive patients157162, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9999]], camposKey:0940-1334 2006-03-01 Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia106111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11705]], camposKey:1576-0367 2006-01-01 Alterations in functon and visual area of schizophrenia Alteraciones de la función y el área visuales en la esquizofrenia3546, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10003]], camposKey:0302-282X 2006-01-01 No association between dorsolateral prefrontal gray matter deficit and N-acetyl aspartate ratios in schizophrenia171178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15783]], camposKey:1695-0887 2006-01-01 Parámetros indicativos de neurodegeneración8083, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10028]], camposKey:0920-9964 2005-12-01 Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia6171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10034]], camposKey:0925-4927 2005-10-30 Dorsolateral prefrontal cortex contribution to abnormalities of the P300 component of the event-related potential in schizophrenia1726, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9986]], camposKey:0213-6163 2005-10-01 Structural effects of atypical antipsychotics: Implications for the meaning of cortical volume deficit in schizophrenia231242, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10035]], camposKey:1053-8119 2005-10-01 Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene10021006, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9992]], camposKey:0924-9338 2005-06-01 Association between excessive frontal cerebrospinal fluid and illness duration in males but not in females with schizophrenia332338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10039]], camposKey:0007-1250 2005-03-01 Hypofrontality in men with first-episode psychosis203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10041]], camposKey:0920-9964 2005-03-01 N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration209219, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10000]], camposKey:0022-3956 2005-03-01 Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity117127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10031]], camposKey:0033-3158 2005-02-01 Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement1726, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10042]], camposKey:0268-1315 2005-01-01 Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia1318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10019]], camposKey:0920-9964 2004-12-01 An electrophysiological (ERP) component, the recognition potential, in the assessment of brain semantic networks in patients with schizophrenia393404, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9984]], camposKey:0268-1315 2004-07-01 Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia221228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9993]], camposKey:0925-4927 2004-05-30 Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients4556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10025]], camposKey:0302-282X 2004-01-01 Long-term olanzapine treatment and P300 parameters in schizophrenia182188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10037]], camposKey:0925-4927 2003-11-30 Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia153161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10029]], camposKey:0925-4927 2003-11-30 Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia163175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10030]], camposKey:1053-8119 2003-07-01 Influence of the normalization template on the outcome of statistical parametric mapping of PET scans601612, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10032]], camposKey:0920-9964 2003-03-01 Cerebral metabolism and risperidone treatment in schizophrenia17, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10047]], camposKey:0925-4927 2003-02-15 Cerebral metabolic patterns in chronic and recent-onset schizophrenia125135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10045]], camposKey:0920-9964 2002-12-01 Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia305312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37800]], camposKey:1029-8428 2002-08-01 Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia437451, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11706]], camposKey:1945-7928 2002-01-01 Effect of the normalization template in statistical parametric mapping of PET scans851854, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=15782]], camposKey:0210-7279 2002-01-01 Técnicas de neuroimagen y diagnóstico de la esquizofrenia80, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11707]], camposKey:0277-786X 2001-07-03 Multimodality image quantification using Talairach grid13851392, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37801]], camposKey:1354-6805 2001-07-03 The Wisconsin Card Sorting Test and the assessment of frontal function in obsessive-compulsive patients: An event-related potential study109129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10046]], camposKey:0920-9964 2001-04-15 P300 amplitude as a possible correlate of frontal degeneration in schizophrenia121128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9998]], camposKey:0165-1781 2001-02-14 Auditory P300 event related potential acid serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients7581, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11708]], camposKey:0210-0010 2001-02-01 The P300 component of evoked potentials in the evaluation of schizophrenia: New evidence and visions of the future El componente P300 de los potenciales evocados en la valoración de la esquizofrenia: Nuevas evidencias y visiones de futuro250258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9989]], camposKey:0161-5505 1998-04-01 Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal624628, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60074]], camposKey:0165-1781 1998-01-16 Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia2128, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9987]], camposKey:0925-4927 1997-11-28 Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A Tc-99m-HMPAO study5161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9978]], camposKey:0920-9964 1997-05-03 Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study1120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10001]], camposKey:0028-3932 1997-04-01 The Wisconsin Card Sorting Test and the assessment of frontal function: A validation study with event-related potentials399408, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11709]], camposKey:0212-6982 1997-01-01 Assessment of cerebral perfusion by SPECT in Gilles de la Tourette syndrome Valoracion de la perfusion cerebral mediante SPECT en el sindrome de Gilles de la Tourette99103, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9982]], camposKey:0002-953X 1996-10-01 SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine13431346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11710]], camposKey:0212-6982 1996-01-01 Regional cerebral perfusion and response to clozapine in refractory schizophrenia Perfusion cerebral regional y respuesta a la clozapina en la esquizofrenia resistente al tratamiento317324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60075]], camposKey:0210-9395 1996-01-01 The study of high cognitive functions using computerised cerebral electrical cartography: Technical and methodological criteria El estudio de las funciones cognitivas superiores mediante cartografía eléctrica cerebral computadorizada: Criterios de rigor técnico y metodológico2744, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9988]], camposKey:0161-5505 1995-12-01 DRUG-THERAPY AND CEREBRAL PERFUSION IN OBSESSIVE-COMPULSIVE DISORDER22342238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9977]], camposKey:0302-282X 1995-01-01 CEREBRAL PERFUSION, ELECTRICAL-ACTIVITY AND EFFECTS OF SEROTONERGIC TREATMENT IN OBSESSIVE-COMPULSIVE DISORDER - A PRELIMINARY-STUDY139148, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11711]], camposKey:0213-0599 1995-01-01 Event-related potentials in the study of memory LES POTENCIALES EVOCADOS EN EL ESTUDIO DE LA MEMORIA150155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11712]], camposKey:0213-0599 1994-12-01 Changes of the regional cerebral perfusion in chronic schizophrenia after treatment with clozapine. Preliminary data CAMBIOS EN LA PERFUSION CEREBRAL REGIONAL EN LA ESQUIZOFRENIA CRONICA TRAS TRATAMIENTO CON CLOZAPINA. DATOS PRELIMINARES399403, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11715]], camposKey:0213-0599 1994-01-01 Application of phosphorus nuclear magnetic resonance spectroscopy to the study of schizophrenia APLICACIONES DE LA ESPECTROSCOPIA DE RESONANCIA MAGNETICA NUCLEAR DE FOSFORO EL ESTUDIO DE LA ESQUIZOFRENIA320328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11716]], camposKey:0213-0599 1994-01-01 Care and treatment of the aggressive patient (2nd part) CUIDADOS Y TRATAMIENTO DEL PACIENTE VIOLENTO (2.A PARTE)167170, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11717]], camposKey:0213-0599 1994-01-01 Care and treatment of the violent patient (1st part) CUIDADOS Y TRATAMIENTO DEL PACIENTES VIOLENTO (1.A PARTE)135139, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11718]], camposKey:0213-0599 1994-01-01 Cerebral blood flow in an obsessive-compulsive disorder: Study with quantified Tc99m-SPECT, before and after treatment FLUJO SANGUINEO CEREBRAL EN EL TRASTORNO OBSESIVO-COMPULSIVO: UN ESTUDIO CON TC99M-SPECT CUANTIFICADO, ANTES Y DESPUES DEL TRATAMIENTO96101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11713]], camposKey:0213-0599 1994-01-01 Functional techniques of neuroimaging and obsessional-compulsive disorder TECNICAS FUNCIONALES DE NEUROIMAGEN Y TRASTORNO OBSESIVO-COMPULSIVO201206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11714]], camposKey:0210-8348 1994-01-01 Influence of sonic stress on performance and brain electrical activity during attentional visual tasks INFLUENCIA DEL ESTRES AUDITIVO EN LA EJECUCION Y EN LOS PATRONES ELECTROENCEFALOGRAFICOS DURANTE LA REALIZACION DE TAREAS DE ATENCION VISUAL: UN ESTUDIO PRELIMINAR4956][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=16900]},camposKey: 77 84 Aspectos psiquiátricos de las demencias 8491131434Enfermedad de Alzheimer y otras demencias neurodegenerativas 1 null Elsevier , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13913]},camposKey: 751 755 Analysis of Functional Connectivity During an Auditory Oddball Task in Schizophrenia 3319466682Converging Clinical and Engineering Research on Neurorehabilitation II 1 2016-11-13 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=27978]},camposKey: 167 170 Caracterización de la Dinámica en la Eficiencia de la Red Neuronal en Esquizofrenia en Tarea Cognitiva Auditiva 978-84-608-3354-3XXXIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica (CASEIB 2015) 1 2015-01-01 Sociedad Española de Ingeniería Biomédica (SEIB), CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=4644]},camposKey: 103 109 Los límites de la cordura 8478670785Creatividad y neurociencia cognitiva 1 2012-01-01 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=4645]},camposKey: 153 170 Asistencia inmediata al niño con mielomeningocele. Revisión bibliográfica 8485281861La carne de Cristo 1 1989-01-01 Universidad Pontificia Comillas ; Institut Borja de Bioètica ][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=119182],camposKey=978-84-1320-134-4La esquizofrenia no existe 1 2021-01-01 Universidad de Valladolid}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=103650],camposKey=978-84-7867-078-9Creatividad y neurociencia cognitiva = Creativity and cognitive neuroscience 1 2012-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=103652],camposKey=978-84-9940-289-5La psicosis: ideas sobre la locura 1 2012-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=103651],camposKey=978-84-9742-931-3Las puertas abiertas de la cordura: no tan diferentes 1 2009-01-01 }][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61052]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64255]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62355]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61052]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64255]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62355]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=186]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=188]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=189]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=186]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=188]], com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=189]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31110]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30811]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30759]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30121]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145640381]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638614]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638440]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7fe26eaa, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7203bb08, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@29bce5fe, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@147ece06, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7805751d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@17b15aee, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@59ecdef3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3b803536, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@687e12c6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7585430d][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da8a8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373200, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373406, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326a][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1188]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f7c9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5be272], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c1d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463425], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463426], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463428], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463427], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414d45], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4647a7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46342a]][][][][][][][]
